Lisa Bright Net Worth & Insider Trades
Lisa Bright - President, Intercept Pharmaceuticals, Inc
What is Lisa Bright's Net Worth?
The current estimated net worth of Intercept Pharmaceuticals, Inc's President, Lisa Bright, is estimated to be about $2.33M . Lisa Bright owns about 18,732 units of Intercept Pharmaceuticals, Inc common stock. In the last 5 years at Intercept Pharmaceuticals, Inc, Lisa Bright has sold an estimated value of $2.82M worth.
What is Lisa Bright's Past Insider Trading?
Lisa Bright's largest sale order was 5,000 units , worth over $557.12K on December 6, 2018. In total, Lisa Bright has made about 43 transactions over 5 years of their time at Intercept Pharmaceuticals, Inc. Lisa Bright usually trades in January, with the busiest year in 2017. The most recent transaction was a sale order of 595 units , worth over $44.63K on October 31, 2019.
Lisa Bright
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Lisa Bright's Salary in 2020?
As President of Intercept Pharmaceuticals, Inc, Lisa Bright has a total base salary of $480,552 . Lisa Bright received compensation valued at about $2,239,784 in 2020 after becoming President. The vast majority of their compensation came in the form of stock awards of $925,704 , option awards of $453,467 , other earnings, plans or compensations of $240,955 , and other compensation of $139,106 .
What is Lisa Bright's' Mailing Address?
- Mailing address is 450 W. 15th Street, Suite 505 New York NY 10011 NY
Intercept Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Mark Pruzanski, M.D., | 2020 | $757,850 | - | $4,113,504 | $1,015,996 | $531,995 | $7,660 | $6,427,005 |
| Mark Pruzanski, M.D., | 2019 | $734,292 | - | $4,197,742 | $1,116,118 | $560,265 | $7,368 | $6,615,785 |
| Mark Pruzanski, M.D., | 2018 | $702,000 | - | $1,667,718 | $1,705,358 | $442,260 | $8,623 | $4,525,960 |
| Jerome Durso, | 2020 | $599,524 | - | $2,057,016 | $998,776 | $231,737 | $21,910 | $3,908,963 |
| Jerome Durso, | 2019 | $573,250 | - | $2,089,570 | $1,238,321 | $359,284 | $21,368 | $4,281,793 |
| Jerome Durso, | 2018 | $540,800 | - | $1,554,326 | $775,844 | $292,032 | $22,403 | $3,185,406 |
| Sandip Kapadia, | 2020 | $476,863 | - | $1,087,836 | $528,088 | $184,039 | $21,910 | $2,298,736 |
| Sandip Kapadia, | 2019 | $464,100 | - | $1,001,664 | $586,573 | $252,935 | $21,368 | $2,326,640 |
| Sandip Kapadia, | 2018 | $442,000 | - | $790,164 | $393,544 | $228,735 | $22,403 | $1,876,846 |
| Richard Kim, | 2020 | $456,095 | - | $1,044,360 | $505,128 | $168,056 | $79,211 | $2,252,850 |
| Richard Kim, | 2019 | $442,900 | $202,800 | $890,368 | $521,398 | $265,519 | $76,343 | $2,399,328 |
| Lisa Bright, | 2020 | $480,552 | - | $925,704 | $453,467 | $240,955 | $139,106 | $2,239,784 |
| Ryan Sullivan, | 2020 | $437,107 | - | $1,087,836 | $528,088 | - | $89,942 | $2,142,973 |
| Ryan Sullivan, | 2019 | $445,520 | - | $1,471,902 | $871,713 | $267,089 | $21,368 | $3,077,592 |
| Ryan Sullivan, | 2018 | $376,158 | - | $1,239,112 | $1,190,351 | $229,122 | $173,437 | $3,208,180 |
| Christian Weyer, M.D., M.A.S., | 2020 | $486,731 | - | $925,704 | $453,467 | $170,804 | $21,910 | $2,058,616 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1270073/000110465921055639/tm218121-2_def14a.htm
What are Intercept Pharmaceuticals, Inc's Past Insider Trades?
Intercept Pharmaceuticals, Inc's most recent insider trade came on March 12, 2021 by Srinivas Akkaraju who bought 237,000 units worth $5.02M . In the last 9 years, insiders at Intercept Pharmaceuticals, Inc have sold an estimated value of $1.66B and bought an estimated value of $148.73M worth of shares. Insider trading is most common in January, with the busiest year in 2019. The most active traders at the company are David Shapiro, Chief Medical Officer, Mark Pruzanski, Director, and Lisa Bright, President .
INTERCEPT PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||